Wedbush Reiterates Outperform on Gossamer Bio, Maintains $4 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Laura Chico reiterated an Outperform rating on Gossamer Bio (NASDAQ:GOSS) and maintained a $4 price target.

May 08, 2024 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Laura Chico reaffirmed an Outperform rating on Gossamer Bio with a $4 price target.
The reiteration of an Outperform rating and maintenance of a $4 price target by a reputable analyst like Laura Chico from Wedbush could instill confidence among investors and potentially lead to a positive short-term impact on Gossamer Bio's stock price. Analyst ratings, especially from well-regarded financial institutions, can significantly influence investor sentiment and stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100